2D Ex Vivo Patient-derived AML Platform for testing Molecular-Targeted Therapies

Presented by

Bandana Vishwakarma, PhD, Scientist in Hematology Oncology at Champions Oncology

About this talk

Champions Oncology was excited to participate in the American Association of Cancer Research’s (AACR) Virtual Meeting in June. Due the limited availability of access to these posters, we wanted to give you direct access to our expert researchers and all the details of the newest innovations happening at Champions. Therefore, we have set up Poster Talks with each presenter so that you can register, attend and ask questions live during each session – just like you were at AACR2020 face-to-face. The key poster takeaways you will learn by watching this webinar are: •Phenotyping, media optimization and reproducibility in AML models. •2D AML platform and its applications evaluating small molecule inhibitors. •Ex vivo and in vivo sensitivity to Ara-C.

Related topics:

More from this channel

Upcoming talks (1)
On-demand talks (48)
Subscribers (2563)
Champions Oncology delivers innovative solutions to oncology drug development, accelerating the journey from the research bench to the clinic – decreasing timelines, lowering costs, and ultimately saving patient lives. Learn more about Champions Oncology's capabilities, our service platforms and educational topics affecting our industry on our Webinar Channel.